AzTrials
AzTrials

Ultrasound Therapy; ComplicationsACTIVENCT03144895

Arterial Catheterization by Ultrasound

A study testing Laying a radial or femoral arterial catheter in people with Ultrasound Therapy; Complications and Intensive Care Unit, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Monitoring of invasive blood pressure and / or cardiac output of resuscitation patients is required and recommended Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Laying a radial or femoral arterial catheter
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
288 participants
Where
1 siteFrance
Study dates
29 Mar 2017to 15 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age over 18 years;
  • Hospitalization in resuscitation;
  • Necessity of installation of an arterial catheter
  • Signed informed consent.
  • Affiliation to a social security scheme

Who cannot join

  • Patient under tutorship or curatorship
  • Minor Patient

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Amiens Picardie

    Amiens, Picardie, 80054

Other trials in France

About this study

Official title: Arterial Catheterization by Ultrasound: Impact on Success Rates and Complications in Patients Hospitalized in Resuscitation

Monitoring of invasive blood pressure and / or cardiac output of resuscitation patients is required and recommended

Read the detailed description

Monitoring of invasive blood pressure and / or cardiac output of resuscitation patients is required and recommended. The installation of an arterial catheter in intensive care is very frequent and subject to many complications. These complications are now well recognized in the literature, they are mainly vascular, infectious and thrombotic. They are directly influenced by the number of attempts to puncture and the time taken to perform the gesture. Many measures are taken to reduce the impact such as the choice of the site of installation, the strict aseptic techniques during the installation and the type of catheter used. However, despite these measures, it appears that the incidence of these complications remains high. Compared to anatomical marking, only the technique of laying the ultrasound-guided catheter has shown its effectiveness in reducing these complications. The management in intensive care of increasingly complicated, severe, elderly patients with significant comorbidities increases from year to year. To the knowledge of the investigator, there is no study on the impact of ultrasound arterial catheterization in patients in resuscitation.

Being tested
Laying a radial or femoral arterial catheter

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laying a radial or femoral arterial catheterProcedure or surgery

    Laying a radial or femoral arterial catheter

Study groups in NCT03144895
Study groupRoleWhat they receive
Arterial catheterOtherby anatomical placement alone
Receives: Procedure: Laying a radial or femoral arterial catheter
PlacementOtherof an arterial catheter by ultrasound tracking
Receives: Procedure: Laying a radial or femoral arterial catheter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success rate of arterial or femoral catheter placement

    at the first attempted puncture (with only one puncture point on the skin).

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2017
  2. Study start29 Mar 2017
  3. Primary completion15 Apr 2025
  4. Study completion15 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
288 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03144895
Sponsor's protocol ID
PI2016_843_0014
Acronym
ACTIVE
Status last verified
Jun 2026
First submitted
2 May 2017
Last updated
11 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Flumignan RL, Trevisani VF, Lopes RD, Baptista-Silva JC, Flumignan CD, Nakano LC. Ultrasound guidance for arterial (other than femoral) catheterisation in adults. Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD013585. doi: 10.1002/14651858.CD013585.pub2.

    PubMed 34637140

Questions about this trial

What is this clinical trial studying?

A study testing Laying a radial or femoral arterial catheter in people with Ultrasound Therapy; Complications and Intensive Care Unit, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success rate of arterial or femoral catheter placement (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03144895, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in